Palliative care in the treatment of women with breast cancer: a scoping review protocol

Introduction: Palliative care is an approach that improves patients' quality of life and their families when they face problems inherent to a life-threatening illness. In the current scenario where breast cancer ranks first among the most common types of cancer in women, research has revealed little control by these patients over the symptoms of the disease and its treatment, resulting in poor quality of life, which should be the focus of attention of palliative care. Thus, the purpose of this study is to map and synthesize the available evidence on palliative care in treating breast cancer women. Methods: This scoping review protocol was elaborated following the methodological recommendations proposed by the Joanna Briggs Institute (JBI) and the PRISMA Extension for Scoping Reviews (PRISMA-ScR) checklist. All study designs, experimental studies, observational studies, qualitative studies, mixed studies, and reviews reporting the palliative care for breast cancer women, will be considered. The following electronic databases will be searched: MEDLINE (via PubMed), Embase, Cochrane Library, Web of Science, Scopus, JBI Evidence Synthesis, Epistemonikos, CINAHL (via EBSCO), LILACS, and the electronic repository SciELO. In addition, The British Library, Google Scholar, Preprints for Health Sciences [medRXiv], Open Grey, Who Library Database, ProQuest Global Dissertations and Theses, ClinicalTrials.gov, and the WHO International Clinical Trials Registry Platform will be searched. No language or date restriction will be applied in the search strategy. Two investigators will independently select studies and perform data extraction and critical appraisal using the using JBI design-specific tolos. A narrative synthesis of the evidence will be carried out and will be grouped and presented in tables and graphic models. Also, a similarity analysis will be performed using IRaMuTeQ software version 0.7 alpha 2, leading to textual categories and themes. Expected Results: The findings of this review will help to identify the gaps for the design of future primary research on women with breast cancer in palliative care. Ultimately, will position care services, managers, and health professionals in the knowledge of the phenomenon, so that they can implement the best evidence-based palliative care practices and improve the quality of care provided to breast cancer patients. Open Science Framework Registration: osf.io/5bwq7


97
Talking about palliative care (PC) today is an interesting challenge due to the complex 98 heterogeneity of conceptions that emerge from this term. However, PC is not a new concept.
99 Saunders [1], the forerunner of the "modern philosophy of hospice," already emphasized in 100 1978 the importance of PC in the care of patients with serious illnesses, a premise that 101 today, with the increase in life expectancy and scientific progress of medical sciences has 102 become more relevant. The growing incidence-prevalence of chronic-degenerative diseases 103 has prolonged the "death process", making it essential to integrate PC into care process 104 towards the end of life. 105 It is stand out that only 14% of people who need palliative care receive it worldwide.
106 It is estimated that, annually, 40 million people need PC; 78% of them live in low-and middle-107 income countries that lack training and awareness of PC among health professionals, a 108 major obstacle in addition to the lack of public and government policies aimed at the 109 implementation of PC at the different levels of health care [2].  is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint  is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint  is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

206
Participants: All studies addressing women, from a young age, will be included,   is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted March 22, 2022. ; https://doi.org/10.1101/2022.03.21.22272710 doi: medRxiv preprint 220 ("in situ"), where it generally causes no symptoms and has minimal potential for spread 221 (metastasis). Over time, these in situ (stage 0) cancers may progress and invade the 222 surrounding breast tissue (invasive breast cancer) then spread to the nearby lymph nodes 223 (regional metastasis) or to other organs in the body (distant metastasis)".

226
Studies whose participants have breast cancer diagnosed with other pathologies will 227 be excluded. In addition, studies with male patients with breast cancer will also be excluded.

229
Search strategy

230
The search strategy will be carried out systematically in eight electronic databases: is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint . Initially, all the articles from the general search will be deposited in the 282 RAYYAN software. Then, the duplicates will be removed, and a representative sample of 283 the articles will be taken to evaluate the level of concordance and report the degree of 284 agreement between the two reviewers. Cohen's kappa coefficient will be used to estimate 285 the index of agreement between the 2 evaluators in each review phase [32].

286
After this phase, the articles will be assessed by titles and abstracts by two 287 independent researchers to identify potentially eligible articles, and another reviewer will 288 resolve any uncertainty regarding the inclusion of a study. Two reviewers will independently . CC-BY 4.0 International license It is made available under a perpetuity.
is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted March 22, 2022. ; https://doi.org/10.1101/2022.03.21.22272710 doi: medRxiv preprint 289 examine the full manuscripts that passed the first selection, and a third reviewer will resolve 290 any decision conflict to obtain a definitive list of studies.

292
Data charting

293
The data will be extracted through a form designed by a research team member  The hierarchy of evidence [37] will classify the selected studies. This classification is 303 divided into seven hierarchical levels, as described in Table 1. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

318
A narrative synthesis of the evidence will be carried out, and the primary quantitative 319 data of the included studies will be tabulated. The results will be grouped and presented in 320 tables, and graphic models. Similarity analysis obtained using the IRaMuTeQ software 321 version 0.7 alpha 2 (Interface de R pour les Analyses Multidimensionnelles de Textes et de 322 Questionnaires) will be carried out through textual categories, as appropriate, to define the 323 final themes.

325
Palliative care is essential in treating women with breast cancer, not only because it 326 comprehensively addresses their symptoms but also because it improves their quality of life, 327 and its delivery must be initiated from the diagnosis of the disease. The findings of this 328 review will help to identify the gaps for the design of future research on PC in breast cancer.
329 Ultimately, will position care services, managers, and health professionals in the knowledge 330 of the phenomenon, so that they can implement the best evidence-based PC, consequently 331 improving the quality of care provided to breast cancer patients.

332
As strong points, this scoping review follows all the methodological recommendations 333 proposed by the JBI. An extensive literature search will be conducted in 9 databases 1 334 electronic repository. A librarian will guide search strategies, and the final version of this 335 protocol was reviewed and approved by a group of 3 specialists: a breast cancer specialist, 336 a PC specialist, and a scoping review specialist.
. CC-BY 4.0 International license It is made available under a perpetuity.
is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted March 22, 2022.
. CC-BY 4.0 International license It is made available under a perpetuity.
is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted March 22, 2022. ; https://doi.org/10.1101/2022.03.21.22272710 doi: medRxiv preprint